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Abstract
Background: Cimetidine, refereed as antiandrogenic drug, causes hormonal changes in male
patients such as increased testosterone and FSH levels. In the rat testis, structural alterations in the
seminiferous tubules have been related to germ cell loss and Sertoli cell death by apoptosis.
Regarding the important role of Sertoli cells in the conversion of testosterone into estrogen, via
aromatase, the immunoexpression of estrogen receptors-beta (ERbeta) was evaluated in the germ
cells of untreated and treated rats with cimetidine. A relationship between ERbeta
immunoreactivity and apoptosis was also investigated in the germ cells of damaged tubules.
Methods: Immunohistochemistry for detection of ERbeta and TUNEL method were performed
in testicular sections of adult male rats treated with 50 mg/Kg of cimetidine (CmG) or saline
solution (CG) for 52 days.
Results: In CG, a cytoplasmic immunoexpression for ERbeta was observed in spermatogonia,
primary spermatocytes and spermatids. An evident ERbeta immunoreactivity was always observed
in the flagellum and residual bodies of late spermatids. In CmG, the cytoplasm or cytoplasm and
nuclei of germ cells of the damaged tubules by cimetidine showed enhanced ERbeta
immunostaining. TUNEL-labeling was usually observed in the same germ cell types exhibiting
enhanced ERbeta immunoreactivity.
Conclusion: The presence of ERbeta immunolabeling in the flagellum and residual bodies of
spermatids reinforces the role of estrogen in spermiogenesis. The overexpression of ERbeta in the
germ cells of CmG could be related to a possible interference of cimetidine on tubular
androgenization and/or on the intratubular aromatase due to Sertoli cell damage. The parallelism
between ERbeta overexpression and apoptosis indicates a participation of ERbeta on germ cell
death.
Background
Additionally to testosterone, studies have demonstrated
that estrogens play also a role in the local regulation of
spermatogenesis [1-6]. Testosterone is converted into
estrogens via cytochrome P450 - an aromatase enzyme
[7]. In the testis, this enzyme is present in Sertoli and Ley-
dig cells [1,8], and has also been detected in germ cells
[1,3,4,8], suggesting that estrogen is locally produced
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from testosterone in the seminiferous epithelium. It has
been demonstrated that the effect of estrogen action on
the reproductive system is mediated by two estrogen
receptors, ERα and ERβ [4,6,9-11]. In the testis, ERβ is sig-
nificantly expressed in comparison to ERα, mainly in the
germ cells [12]. This type of receptor has been detected in
germ cells of humans [13-17], rodents [2,10,18-20], and
other mammalian species [11,21], indicating that estro-
gens play a physiological role in the spermatogenic proc-
ess via ERβ.
In young and adult rodents, ERβ has been detected immu-
nohistochemically in gonocytes, spermatogonia [2,18],
pachytene spermatocytes and spermatids [2,10,18,20].
The presence of ERβ in spermatocytes, round [2,10,18]
and elongate spermatids [3] has indicated a role of estro-
gens on spermatid maturation. This role has been rein-
forced by the fact that deficiency of aromatase leads to
reduction in the number of spermatids [22]. On the other
hand, low doses of estrogen can potentially cause severe
spermatogenic cellular dysfunction [23]. Estrogen induces
up-regulation of Fas and FasL in adult rat testis, resulting
in the germ cell apoptosis [24]. It has been demonstrated
that either extrinsic (cell death receptors) or intrinsic
(mitochondria) pathways are involved in the estrogen-
induced germ cell apoptosis [23].
Cimetidine is an H2-receptor antagonist that inhibits acid
secretion and is clinically used for the treatment of gastric
and duodenal ulcers [25]. However, some adverse effects
have been described in male patients: a) loss of libido and
impotence; 2) increased levels of FSH and testosterone
[26] and 3) gynaecomastia [27]. The effects of cimetidine
in adult castrated male rats androgenized with testoster-
one revealed a significant decrease in ventral prostate and
seminal vesicle weights [28]. Moreover, this drug com-
petes for tritiated dihydrotestosterone-binding sites in
mouse kidney preparations [29]. Thus, this drug has dem-
onstrated to be an anti-androgenic agent, competing for
androgen receptors [28-30].
In male rats, cimetidine has caused increased FSH levels
[31], reduction in testicular weight [32,33] and structural
alterations in the seminiferous tubules [31,33-36], includ-
ing loss of germ cells by apoptosis [35]. The tubular alter-
ations have suggested a possible antiandrogenic effect of
cimetidine on the tubular androgenization [33,34].
Besides these effects, cimetidine induces peritubular
myoid cell death [31,35] and structural alterations in the
Sertoli cell-basement membrane interface leading to Ser-
toli cell apoptosis [36]. Considering the antiandrogenic
effect of cimetidine and the important role of Sertoli cells
in the conversion of testosterone into estrogen, via aro-
matase, the immunoexpression of estrogen receptors
(ERβ) in the germ cells of untreated and treated rats with
cimetidine was evaluated. A relationship between ERβ
immunoreactivity and apoptosis was also investigated in
the germ cells of damaged tubules.
Methods
Animals and treatment
Ten adult Holtzman male rats weighing 250-300 g were
maintained at 25°C, standard lighting conditions (12-h
light/dark cycle), fed laboratory rat chow and given water
ad libitum. The animals were grouped in control (CG) and
cimetidine (CmG) groups containing five animals each.
The animals from CmG received daily intraperitoneal
injections containing aqueous solution of 50 mg of cime-
tidine (Tagamet®, SmithKline Beecham, Brazil) per kg of
body weight for 52 days, period of a complete sperma-
togenic cycle [37]. The animals from CG received saline
solution by the same route. Principles of laboratory ani-
mal care and national laws on animal use were observed.
The protocol of this study was authorized by Ethical Com-
mittee for Animal Research of the Dental School of São
Paulo State University (UNESP-Araraquara).
Light microscopy
The animals were anaesthetised and sacrificed with chlo-
ral hydrate and the testes were fixed in 4% formaldehyde
(freshly prepared from paraformaldehyde) buffered at pH
7.2 with 0.1 M sodium phosphate for 48 hours at room
temperature. Subsequently, the specimens were dehy-
drated in graded ethanol and embedded in paraffin for
detection of ERβ by immunohistochemistry and cell
death by TUNEL method. Pieces of uterus from female
rats were fixed in the same fixative and embedded in par-
affin to be used as positive control for the immunohisto-
chemistry.
Immunohistochemistry for ER
Testicular and uterine sections - used as positive control
[38], were adhered to silanized slides, hydrated and main-
tained in citrate buffer (0.001 M; pH 6.0), for 20 min., in
a microwave oven (90°C) for activation of antigen. The
sections were immersed in 3% hydrogen peroxide (10
min.) for inactivation of endogenous peroxide. After
washings in Tris-HCl 0.05 M; pH 7.5 buffer (TBS), the sec-
tions were incubated in primary antibodies (rabbit poly-
clonal IgG anti-rat estrogen receptor-β; Upstate Cell
Signaling Solutions; Lake Placid, NY, USA), 1:200, diluted
in TBS and 5% BSA, at 4°C. After 14 h, the sections were
washed in TBS and incubated in solution containing
biotinylated anti-rabbit antibodies (LSAB-plus kit; DaKO
Corporation, USA) for 30 min. at room temperature,
washed in TBS and incubated with streptavidin-peroxi-
dase complex (LSAB-plus kit; DAKO) for 15 min at room
temperature. After washings in TBS, the reaction wasReproductive Biology and Endocrinology 2009, 7:127 http://www.rbej.com/content/7/1/127
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revealed with 0,06% 3.3'-diaminobenzidine tetrahydro-
chloride (DAB - Sigma-Aldrich Chemical Co., St. Louis,
USA). The sections were counterstained with haematoxy-
lin, dehydrated and mounted in resin. To be sure that the
immunoreaction could not be resulted from unspecific
staining, testicular sections from CG and CmG, used as
negative controls, were performed following the same
protocol, except that the incubation in the primary anti-
body was replaced by incubation in non-immune serum.
The morphological analysis and capture of images were
made by using light microscopes (Olympus, BX-50 and
BX-51).
Evaluation of the immunoreactivity
Four testicular sections per animal from CG and CmG
were used. In each section, the ERβ-positive germ cells in
six seminiferous tubules per section were analyzed accord-
ing to the intensity of ERβ immunolabeling and scored as
weak (+), moderate (++) or strong (+++) [10].
TUNEL method
The TUNEL (Terminal deoxynucleotidyl-transferase-
mediated dUTP Nick End Labeling) method was per-
formed as previously described [35,36]. The sections
adhered to silanized slides (3-aminopropyltrithoxysylane
- Sigma-Aldrich Chemical Co., St. Louis, USA) were
treated with 20 μg/ml proteinase K (Sigma-Aldrich Chem-
ical Co., St. Louis, USA) and immersed in 3% hydrogen
peroxide. After immersion in equilibration buffer, the sec-
tions were incubated in TdT enzyme at 37°C and, after 1
hour, the reaction was stopped with stop/wash buffer. The
sections were incubated in anti-digoxigenin-peroxidase
for 30 min and the reaction was revealed with 0.06% 3.3'-
diaminobenzidine tetrahydrochloride (DAB - Sigma-
Aldrich Chemical Co., St. Louis, USA) and counterstained
with Carazi's haematoxylin. Sections of involuting mam-
mary gland, provided by the manufacturer of the Kit, were
used as positive controls for the TUNEL method. Negative
controls were incubated in a TdT enzyme-free solution.
Results
Immunohistochemistry for ER
The uterine sections, used as positive control, revealed an
evident immunoreactivity in the epithelium, endometrial
glands and muscle tissue (Fig. 1A). In the testicular sec-
tions, used as negative control, none immunoreactivity
was observed (Fig. 1B).
In CG, an evident cytoplasmic immunostaining for estro-
gen receptors (ERβ) was observed in the germ cells of the
basal compartment (spermatogonia and leptotene sper-
matocytes) and in zygotene to diplotene spermatocytes in
almost all stages (II-XIII). Round spermatids (stages II-
VIII) showed a weak cytoplasmic immunostaining (Figs
1C-G). However, a conspicuous staining was noted in the
residual bodies derived from elongate spermatids in the
tubules at stages VII and VIII and in the caudal portion of
elongating spermatids in tubules at stage IX (Figs. 1D and
1E).
The seminiferous epithelium of rats from CmG exhibiting
lack of elongate spermatids, intraepithelial vacuoles and
detached germ cells in the tubular lumen showed a similar
immunostaining pattern to those of the control group.
However, the nuclei of some round spermatids were also
immunolabeled and a strong immunostaining was
observed in the detached germ cells filling the tubular
lumen (Fig. 2A). In the seminiferous tubules with severe
1A-1G: Immunohistochemistry for detection of ERβ in the  uterus (positive control) and in the testes of rats from CG Figure 1
1A-1G: Immunohistochemistry for detection of ERβ 
in the uterus (positive control) and in the testes of 
rats from CG. In 1A, strong immunolabeling is observed in 
the epithelium (thin arrow) and endometrial gland (thick 
arrow). The connective (C) and muscle (M) tissues show a 
weak and moderate immunopositivity, respectively. In 1B, 
none immunolabeling is observed in the testicular section 
used as negative control. In 1C-1G, immunostaining is uni-
formly observed in the cytoplasm of germ cells of the basal 
compartment (short arrows), primary spermatocytes (long 
arrows), round and elongate spermatids (asterisks). An 
accentuated staining (arrowheads) is observed in the residual 
bodies (1D) and in the caudal portion of early elongating 
spermatids (1E). Scale bars: 100 μm (1A); 60 μm (1B); 10 μm 
(1C); 21 μm (1D and 1E); 15 μm (1F and 1G).Reproductive Biology and Endocrinology 2009, 7:127 http://www.rbej.com/content/7/1/127
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cellular depletion (Table 1), a strong immunopositivity
was found in both nuclei and cytoplasm of spermatids, in
the cytoplasm of primary spermatocytes and in the germ
cells of the basal compartment (Figs. 2B-G). In late sper-
matids (tubules at stages II-V), a strong positive immu-
nolabeling was observed in the residual bodies (Fig. 2F).
Multinucleated giant cells derived from altered round
spermatids showed nuclei with peripheral condensed
chromatin (typical of apoptosis) and were also strongly
positive to the immunoreaction (Fig. 2H). In the maxi-
mally damaged tubules, some germ cell nuclei in the basal
portion of the epithelium were strongly stained; some of
them were inside a vacuole, next to Sertoli cell nucleus
(Fig. 2I).
ER  immunostaining and TUNEL-positive germ cells
In the damaged seminiferous tubules of cimetidine-
treated rats, the TUNEL labeling was observed in the same
germ cell types strongly immunostained for ERβ, i.e. pri-
mary spermatocytes, round and elongate spermatids and
giant multinucleated cells. In the ERβ-immunostained
cells, the nuclei also showed degenerative aspects, such as
condensed chromatin, typical of apoptosis (Figs. 3A-J).
Discussion
ER  immunoreactivity in untreated rats
In the present study, the cellular ERβ immunolabeling
was observed in spermatogonia, primary spermatocytes
and spermatids, similarly to previous findings
[2,10,18,20,39]. However, the immunoreactivity was
always observed in the cytoplasm of these germ cells.
Although ER is considered a nuclear receptor, the actual
cellular localization of the estrogen receptors has been
controversial. Estrogen modulates mitochondrial func-
tion, such as ATP production, mitochondrial membrane
potential, and calcium concentration [40]. According to
Yang [41], ERβ has demonstrated to be a mitochondrial
protein rather than a nuclear receptor. Moreover, a
number of studies have demonstrated that ERβ is mainly
localized extranuclearly [reviewed by [42]]. Additionally
to the nucleus, ERβ immunolabeling has been demon-
strated in the cytoplasm of different cell types [41-43],
including cells of the reproductive system [2,10,19,39]. A
diffused immunostaining for ERβ has been demonstrated
in the cytoplasm of spermatocytes [2] and in the seminif-
erous epithelium of bank vole [10]. In the testis of rat ABP
transgenic mice, an evident immunostaining has been
observed in the cytoplasm of pachytene spermatocytes
and metaphase germ cells as well as a less intense cyto-
plasmic labeling in the elongate spermatids [19]. Moreo-
ver, ERβ immunostaining was also detected in human
sperm, mainly in the midpiece, at the site where the mito-
chondria are packaged [16]. Thus, in agreement with these
findings, the results of the present study reinforce the
cytoplasmic role of estrogen via ERβ in the germ cells.
2A-2I: Immunohistochemistry for detection of ERβ in the  testicular sections of rats from CmG Figure 2
2A-2I: Immunohistochemistry for detection of ERβ in 
the testicular sections of rats from CmG. In 2A, the 
seminiferous tubule showing slight alterations exhibits a simi-
lar pattern of immunostaining of CG; however, some sper-
matid nuclei (white arrows) and the detached germ cells 
filling the lumen (black arrows) are strongly stained. In the 
damaged tubules (2B-2E), a strong immunopositivity (black 
arrows) is observed in the cytoplasm of primary spermato-
cytes (2B-2D) and germ cells of the basal compartment 
(2E). Note that the immunolabeling is observed in both cyto-
plasm (2B) and nucleus (2C) of spermatids (white arrows). 
In 2F and 2G, strong positive immunolabeling is observed in 
the nucleus of round (2F) and elongating (2G) spermatids 
(arrows) and in the residual bodies (asterisks). In 2H, the 
immunopositive giant multinucleated cells contain spermatids 
with peripheral condensed chromatin (arrows). In 2I, a posi-
tive germ cell is inside a vacuole (arrow) next to Sertoli cell 
nucleus (S). Scale bars: 28 μm (2A and 2D); 20 μm (2B, 2C, 
2E-2I).
Table 1: Scores (weak+, moderate++ and strong+++) of the ERβ 
immunoreactivity in the germ cells of rats from CG and CmG
Germ Cells CG CmG
Spermatogonia ++ +++
Spermatocytes ++ ++/+++
Round spermatids +/++ ++/+++
Elongate spermatids ++ +++
Residual bodies ++/+++ +++Reproductive Biology and Endocrinology 2009, 7:127 http://www.rbej.com/content/7/1/127
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Studies have demonstrated ERβ immunolabeling in
round [2,10,13,18] and elongate spermatids [14]. Moreo-
ver, knockout mice that lack a functional aromatase
enzyme show a specific defect in the development of sper-
matids [22]. Therefore, these findings have confirmed that
estrogen plays a role in the maturation of spermatids. In
the present study, ERβ immunolabeling was observed in
the cytoplasm of elongating spermatids, mainly at stage
IX. Additionally, the residual bodies derivative from the
final steps of spermiogenesis were also immunostained. It
has been discussed that the differences concerning posi-
tivity and negativity in the cytoplasm of these cells are due
to differences in the affinities of the antibodies by the
amino acid sequences: N- or C-terminal region [19,39]. In
these studies, a less intense but clear labeling was also
demonstrated in the luminal compartment, correspond-
ing to caudal portion (cytoplasm) of elongate spermatids
and spermatozoa. The present results are compatible with
the findings obtained by the authors probably due to the
fact that the same amino acids (54-71 amino-terminal
region) of rat estrogen receptor-β, such as used by the
authors [19,39], were used in the present study.
Additionally to the flagellum, the present findings
revealed specific ERβ immunolabeling in the residual
bodies of rat spermatids. These results are in agreement to
previous studies, in which estrogen receptors immunoex-
pression have been demonstrated in excess residual cyto-
plasm [17] of human spermatozoa. In rodents, aromatase
(a key enzyme that convert testosterone to estrogen) is
observed to move from the Golgi apparatus to the cyto-
plasm during spermiogenesis and has been immunolocal-
ized in both flagella and residual bodies [reviewed by [4]].
Therefore, the presence of ERβ in the same portions of
spermatozoa in which aromatase has been detected rein-
forces the fact that spermiogenesis, including the forma-
tion of residual bodies, are estrogen-dependent processes.
ER  immunoreactivity in cimetidine treated rats
In the present study, an accentuated immunoreactivity for
ERβ was observed in the damaged tubules by cimetidine.
Spermatogonia, primary spermatocytes and spermatids in
different steps of spermiogenesis exhibited strong cyto-
plasmic immunolabeling. In some germ cells, mainly
spermatids, a conspicuous nuclear immunoexpression for
ERβ was also observed. Cimetidine has demonstrated to
cause severe alterations in the seminiferous tubules
[31,33-36], including significant decrease in the diameter
of tubules at androgen-dependent stages, detachment of
spermatids from Sertoli cells [33] and germ cell loss by
apoptosis [35]. Thus, a possible interference of cimetidine
in the tubular androgenization has been suggested
[33,34]. However, cimetidine has also demonstrated to
exert a toxic direct effect on the peritubular tissue [31,35].
In a recent study, it has been demonstrated that Sertoli
cell-basement membrane interface is structurally affected
by cimetidine, leading to Sertoli cells death by apoptosis
and significant reduction in the number of these cells
[36]. It is known that Sertoli and germ cells are able to
convert testosterone into estrogens via aromatase enzyme
[1,3,4,8]. Thus, additionally to the antiandrogenic effect
of cimetidine and the possible interference on tubular
androgenization, the convertion of testosterone to estro-
gen by aromatase in the damaged tubules by cimetidine
may be probably affected, due to Sertoli cell death. Studies
have demonstrated a higher estrogen receptor immunore-
activity in different cerebral regions of animals whose
source of estrogen was removed by aromatase inhibitors
3A-3J: Immunohistochemistry for detection of ER-β (Figs.  3A-3E) and TUNEL method (Figs. 3F-3J) in the seminiferous  tubules affected by cimetidine (CmG) Figure 3
3A-3J: Immunohistochemistry for detection of ER-β 
(Figs. 3A-3E) and TUNEL method (Figs. 3F-3J) in the 
seminiferous tubules affected by cimetidine (CmG). 
In 3A-3E, spermatocytes (3A), round (3B and 3C), elongate 
(3E) spermatids and multinucleated cells derived from sper-
matids (3D) are positive for ER-β immunohistochemistry 
(arrows). In these cells (3A-3D), the nuclei show degenera-
tive aspect, typical of apoptosis. In 3F-3J, spermatocytes 
(3F), round (3G), elongate (3J) spermatids and giant multi-
nucleated cells derived from spermatids (3H and 3I) are 
also TUNEL-positive (arrows). Scale bars: 8 μm.Reproductive Biology and Endocrinology 2009, 7:127 http://www.rbej.com/content/7/1/127
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[44,45] or in aromatase knockout (ArKO) mice [46], indi-
cating that estrogen can down-regulates estrogen recep-
tors. Regarding the seminiferous epithelium, a
conspicuous ERβ immunolabeling was also detected in
the germ cells of rat ABP transgenic mouse; in this rat
model, aromatization to estrogen should also be impaired
due to significant disruption in the intratubular androgen
homeostasis [19]. Thus, it is conceivable to suggest that
the increased ERβ immunoreactivity in the germ cells of
affected tubules by cimetidine can be related to a possible
interference of cimetidine on the tubular androgenization
and/or to a possible intratubular aromatase or estrogen
deficiency, due to Sertoli and germ cells damage. This is
reinforced by the fact that cimetidine induces increase in
the FSH levels in men [26] and in rats treated with the
same dosage used in the present study [31]. It has been
demonstrated that estrogen also plays a role in the feed-
back control of FSH concentrations [reviewed by
[4,47,48]]. In men, the suppressive effect of testosterone
on serum FSH is decreased by addition of aromatase
inhibitor (testolactone), which in turn inhibits the con-
version of testosterone into estrogen [47]. Thus, the
increased FSH levels [31] associated to the impairment in
the Sertoli cells caused by cimetidine [35,36] support the
idea that the ER-beta overexpression in the germ cells of
damaged tubules by cimetidine can be related to a possi-
ble intratubular estrogen deficiency. However, further
studies are necessary to confirm this possibility.
Studies have demonstrated a relationship between germ
cell loss by apoptosis and deficiency of estrogen [8] or aro-
matase [22]. In a previous study, a massive germ cell loss
by apoptosis has been demonstrated by TUNEL method
in cimetidine-treated rats [35]. The results of the present
study also revealed a parallelism between TUNEL-labeling
and enhanced ERβ immunoreactivity in the same germ
cell types. Thus, while spermatocytes cytoplasm and cyto-
plasm and nuclei of round and elongate spermatids
showed enhanced ERβ immunoreactivity, these same cell
types were also positive for the TUNEL method, as previ-
ously demonstrated [35] and observed in the present
study. Moreover, germ cells strongly ERβ-immunostained
were within vacuoles next to Sertoli cells, suggesting
phagocytosis, a common event observed during apoptosis
[35]. In a recent study made in our laboratory, a similar
parallelism between cytoplasmic ERβ overexpression and
apoptosis has also been demonstrated in alveolar bone
osteoclasts [49]. According to Nilsen et al. [50], ERβ acts
as a mediator of apoptosis in cultured neurons. In patients
with Alzheimer disease, an increased ERβ immunoreactiv-
ity was detected in the cytoplasm of degenerative neuro-
nal cells of hippocampus [51]. Regarding the germ cells, a
correlation between ERβ overexpression and apoptosis
was also observed either in rat spermatocytes induced to
apoptosis by short-term administration of methoxyacetic
acid [20] or in rat ABP transgenic mouse [19]. In these
studies, the authors suggest that these receptors play a role
in the apoptotic process. Thus, the present findings cor-
roborate to the idea that estrogen receptors (ER-beta) are
related to the induction of apoptosis in the germ cells.
Conclusion
The results of the present study point to the cytoplasmic
role of estrogen via ERβ in the germ cells. The presence of
ERβ immunoreactivity in the flagellum and residual bod-
ies of spermatids reinforces the role of estrogen on rat
spermiogenesis.
Cimetidine interferes in the hormonal control of sperma-
togenesis leading to an accentuated ERβ immunolabeling
in the germ cells. Future studies focusing on a possible
intratubular aromatase deficiency would be useful to clar-
ify the present findings. The parallelism between ERβ
overexpression and apoptosis in the germ cells suggests a
possible role of ERβ in the induction of germ cell death.
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